Measures to improve early results in kidney transplantation

Transplant Proc. 1992 Dec;24(6):2729-30.
No abstract available

MeSH terms

  • Acyclovir / administration & dosage
  • Antilymphocyte Serum / administration & dosage
  • Antilymphocyte Serum / adverse effects
  • Cause of Death
  • Clotrimazole / administration & dosage
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Graft Rejection / drug therapy
  • Graft Rejection / immunology*
  • Graft Rejection / mortality
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Kidney Function Tests*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Muromonab-CD3 / administration & dosage
  • Muromonab-CD3 / adverse effects
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / mortality
  • Pentamidine / administration & dosage
  • Postoperative Complications / drug therapy
  • Postoperative Complications / immunology*
  • Postoperative Complications / mortality
  • Survival Analysis
  • Survival Rate
  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Pentamidine
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Clotrimazole
  • Acyclovir